Individualized Provider Feedback Increased HIV and HCV Screening and Identification in a New York City Emergency Department.


Journal

AIDS patient care and STDs
ISSN: 1557-7449
Titre abrégé: AIDS Patient Care STDS
Pays: United States
ID NLM: 9607225

Informations de publication

Date de publication:
03 2022
Historique:
entrez: 15 3 2022
pubmed: 16 3 2022
medline: 6 4 2022
Statut: ppublish

Résumé

Efforts to end the HIV and hepatitis C virus (HCV) epidemics begin with ascertainment of a person's infection status through screening. Despite its importance as a site of testing, missed opportunities for screening in the Emergency Department (ED) are common. We describe the impact of implementing an individualized provider feedback intervention on HIV and HCV testing in a quaternary ED. We conducted an interrupted time series analysis to evaluate the impact of the intervention on weekly HIV and HCV screening in an observational cohort of patients seeking care in the ED. The intervention included a physician champion individualized feedback with peer comparisons to all providers in the ED and an existing HIV/HCV testing and response team. Data were abstracted from the electronic medical record (EMR) for 30 weeks before, during, and after implementing the intervention. We used Poisson regression analysis to estimate changes in the weekly counts and rates of HIV and HCV testing. The incidence rate ratios (IRRs) of HIV testing were 1.94 [95% confidence interval (CI) 1.85-2.04] and 1.38 (95% CI 1.31-1.45) times higher for the intervention and post-intervention period compared with the pre-intervention period. The IRRs of HCV testing was 6.96 (95% CI 6.40-7.58) and 4.70 (95% CI 4.31-5.13) for the intervention and post-intervention periods. There were no meaningful differences in demographic characteristics during the observation period. The intervention meaningfully increased HIV and HCV testing volume and positive case detection, including testing in high-risk groups like young adults and individuals without prior testing. Although diminished, the intervention effect sustained in the 30-week period following implementation.

Identifiants

pubmed: 35289689
doi: 10.1089/apc.2021.0225
pmc: PMC8971984
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-114

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI150378
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069470
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069470
Pays : United States

Références

Implement Sci. 2021 Oct 24;16(1):92
pubmed: 34689810
JAMA. 2013 Jun 12;309(22):2345-52
pubmed: 23757082
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
Am J Public Health. 2018 May;108(5):652-658
pubmed: 29565667
JAMA. 2020 Mar 2;:
pubmed: 32119034
Cochrane Database Syst Rev. 2019 Dec 18;12:CD001174
pubmed: 31858588
AIDS Patient Care STDS. 2016 Jun;30(6):247-53
pubmed: 27286295
AIDS Patient Care STDS. 2021 May;35(5):180-187
pubmed: 33901410
Liver Int. 2020 Jun;40(6):1282-1291
pubmed: 32267604
AIDS Care. 2021 Oct;33(10):1243-1254
pubmed: 32933322
J Viral Hepat. 2019 Nov;26(11):1355-1358
pubmed: 31325394
Open Forum Infect Dis. 2019 Apr 10;6(5):ofz178
pubmed: 31123691
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
AIDS Patient Care STDS. 2020 Jul;34(7):281-283
pubmed: 32639211
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Implement Sci. 2017 May 12;12(1):61
pubmed: 28494799
Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S126-32.e1-4
pubmed: 21684391
JAMA. 2016 Feb 9;315(6):562-70
pubmed: 26864410
BMJ Qual Saf. 2015 Jun;24(6):393-9
pubmed: 25918432
AMIA Annu Symp Proc. 2018 Dec 05;2018:395-403
pubmed: 30815079
Implement Sci. 2006 Apr 28;1:9
pubmed: 16722539
BMJ Open. 2016 Nov 10;6(11):e012721
pubmed: 28186940
J Womens Health (Larchmt). 2012 Feb;21(2):170-8
pubmed: 21950274
Public Health Rep. 2014 Jan-Feb;129 Suppl 1:12-20
pubmed: 24385644
Med Care. 2009 Mar;47(3):356-63
pubmed: 19194332
Curr HIV/AIDS Rep. 2021 Aug;18(4):391-405
pubmed: 34109549
AIDS Patient Care STDS. 2020 Sep;34(9):373-379
pubmed: 32799540
AIDS Patient Care STDS. 2018 Nov;32(11):432-437
pubmed: 30398951
Cochrane Database Syst Rev. 2017 Jul 06;7:CD001175
pubmed: 28681432
J Ambul Care Manage. 2015 Apr-Jun;38(2):118-24
pubmed: 25748260

Auteurs

Jason Zucker (J)

Division of Infectious Diseases, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Lawrence Purpura (L)

Division of Infectious Diseases, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
ICAP, Mailman School of Public Health, Columbia University, New York, New York, USA.

Fereshteh Sani (F)

Acute Care Services, Attending Physician, Emergency Medicine, Permanente Medicine, Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA.

Simian Huang (S)

Division of Infectious Diseases, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Aaron Schluger (A)

Department of Medicine, Westchester Medical Center, Valhalla, New York, USA.

Kenneth Ruperto (K)

New York Presbyterian Hospital, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Jacek Slowkowski (J)

New York Presbyterian Hospital, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Susan Olender (S)

Division of Infectious Diseases, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Matt Scherer (M)

Division of Infectious Diseases, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Delivette Castor (D)

Division of Infectious Diseases, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Peter Gordon (P)

Division of Infectious Diseases, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH